Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative DOS chemotherapy for clinical stage III gastric cancer
jRCTs051180086Phase 2Completed
- Sponsor
- Yakult Honsha
- Start
- Jun 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, oxaliplatin and tegafur in gastric cancer (GC) and esophagogastric junction cancer, sponsored by Yakult Honsha. Primary endpoint: progression-free survival. Started Jun 2015; status: completed.
02
Drugs
docetaxeloxaliplatintegafur
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on jRCTs051180086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180086.